Diminished retinal complex lipid synthesis and impaired fatty acid β-oxidation associated with human diabetic retinopathy.
Adult
Black or African American
Aged
Arizona
Carnitine
/ analogs & derivatives
Case-Control Studies
Ceramides
/ metabolism
Diabetes Mellitus, Type 2
/ complications
Diabetic Retinopathy
/ etiology
Diglycerides
/ metabolism
Disease Progression
Esters
/ metabolism
Female
Hispanic or Latino
Humans
Lipidomics
Male
Mass Spectrometry
Middle Aged
Mitochondria
/ metabolism
Phosphatidylcholines
/ metabolism
Retina
/ metabolism
Triglycerides
/ metabolism
White People
American Indian or Alaska Native
Diabetes
Fatty acid oxidation
Ophthalmology
Retinopathy
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
08 10 2021
08 10 2021
Historique:
received:
08
06
2021
accepted:
25
08
2021
pubmed:
27
8
2021
medline:
16
3
2022
entrez:
26
8
2021
Statut:
epublish
Résumé
BACKGROUNDThis study systematically investigated circulating and retinal tissue lipid determinants of human diabetic retinopathy (DR) to identify underlying lipid alterations associated with severity of DR.METHODSRetinal tissues were retrieved from postmortem human eyes, including 19 individuals without diabetes, 20 with diabetes but without DR, and 20 with diabetes and DR, for lipidomic study. In a parallel study, serum samples from 28 American Indians with type 2 diabetes from the Gila River Indian Community, including 12 without DR, 7 with mild nonproliferative DR (NPDR), and 9 with moderate NPDR, were selected. A mass-spectrometry-based lipidomic platform was used to measure serum and tissue lipids.RESULTSIn the postmortem retinas, we found a graded decrease of long-chain acylcarnitines and longer-chain fatty acid ester of hydroxyl fatty acids, diacylglycerols, triacylglycerols, phosphatidylcholines, and ceramide(NS) in central retina from individuals with no diabetes to those with diabetes with DR. The American Indians' sera also exhibited a graded decrease in circulating long-chain acylcarnitines and a graded increase in the intermediate-length saturated and monounsaturated triacylglycerols from no DR to moderate NPDR.CONCLUSIONThese findings suggest diminished synthesis of complex lipids and impaired mitochondrial β-oxidation of fatty acids in retinal DR, with parallel changes in circulating lipids.TRIAL REGISTRATIONClinicalTrials.gov NCT00340678.FUNDINGThis work was supported by NIH grants R24 DK082841, K08DK106523, R03DK121941, P30DK089503, P30DK081943, P30DK020572, P30 EY007003; The Thomas Beatson Foundation; and JDRF Center for Excellence (5-COE-2019-861-S-B).
Identifiants
pubmed: 34437304
pii: e152109
doi: 10.1172/jci.insight.152109
pmc: PMC8525591
doi:
pii:
Substances chimiques
Ceramides
0
Diglycerides
0
Esters
0
Phosphatidylcholines
0
Triglycerides
0
acylcarnitine
0
Carnitine
S7UI8SM58A
Banques de données
ClinicalTrials.gov
['NCT00340678']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NEI NIH HHS
ID : R01 EY020895
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK092926
Pays : United States
Organisme : NIDDK NIH HHS
ID : R24 DK082841
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK089503
Pays : United States
Organisme : NIDDK NIH HHS
ID : R03 DK121941
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK020572
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK081943
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY007003
Pays : United States
Organisme : NIDDK NIH HHS
ID : K08 DK106523
Pays : United States
Références
J Transl Sci. 2020 Dec;6(6):
pubmed: 33240530
Diabetol Metab Syndr. 2019 Nov 8;11:92
pubmed: 31719846
JCI Insight. 2017 Jul 20;2(14):
pubmed: 28724805
JAMA. 2010 Aug 11;304(6):649-56
pubmed: 20699456
Biochim Biophys Acta Biomembr. 2017 Sep;1859(9 Pt B):1558-1572
pubmed: 28411170
Dis Model Mech. 2020 Jan 24;13(2):
pubmed: 31822493
J Lipid Res. 2016 Mar;57(3):499-508
pubmed: 26764040
J Neuroinflammation. 2013 Dec 10;10:149
pubmed: 24325836
J Clin Pathol. 1961 Sep;14:496-9
pubmed: 13890362
Kidney Int Rep. 2016 Nov;1(4):256-268
pubmed: 28451650
J Lipid Res. 2018 Feb;59(2):173-183
pubmed: 29237716
Invest Ophthalmol Vis Sci. 2012 Oct 19;53(11):7257-67
pubmed: 22952117
N Engl J Med. 1993 Sep 30;329(14):977-86
pubmed: 8366922
Ophthalmology. 1991 May;98(5 Suppl):786-806
pubmed: 2062513
JCI Insight. 2018 Feb 22;3(4):
pubmed: 29467334
Diabetes. 2010 Jan;59(1):219-27
pubmed: 19875612
Anal Bioanal Chem. 2020 Jun;412(15):3585-3594
pubmed: 32333076
PLoS One. 2014 Sep 04;9(9):e106912
pubmed: 25188352
Diabetes. 2020 Oct;69(10):2217-2226
pubmed: 32737117
Telemed J E Health. 2020 Dec;26(12):1466-1474
pubmed: 32004436
JCI Insight. 2016 Sep 22;1(15):e86976
pubmed: 27699244
Diabetes. 2013 Sep;62(9):3224-31
pubmed: 23545707
Ophthalmic Genet. 2013 Mar-Jun;34(1-2):27-31
pubmed: 22950451
Diabetologia. 2019 Sep;62(9):1539-1549
pubmed: 31346658
JCI Insight. 2018 Jan 11;3(1):
pubmed: 29321376
Diabetes Care. 2012 Mar;35(3):556-64
pubmed: 22301125
Ophthalmology. 2015 May;122(5):949-56
pubmed: 25704318
Diabetes. 2006 Dec;55(12):3573-80
pubmed: 17130506
Diabetes. 2010 Jul;59(7):1780-8
pubmed: 20424229
J Lipid Res. 2015 Mar;56(3):599-611
pubmed: 25598081
J Am Soc Nephrol. 2018 Jan;29(1):295-306
pubmed: 29021384
Ophthalmology. 1981 Jul;88(7):601-12
pubmed: 6167923
JCI Insight. 2019 Nov 1;4(21):
pubmed: 31573977